Futuremeds sp. z o. o.
Olsztyn 10165
2 studies enrolling now · 3 studies all time
What they study most
Atrial Fibrillation, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Heart Failure, Hypertension, Obesity, Prevention of Stroke or Systemic Embolism
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity — Recruiting now
- A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early